1 |
NCT00632853 |
|
2 |
NCT00719303 |
Fallopian Tube Clear Cell Adenocarcinoma |
Fallopian Tube Endometrioid Adenocarcinoma |
Fallopian Tube Mucinous Adenocarcinoma |
Fallopian Tube Serous Adenocarcinoma |
Fallopian Tube Transitional Cell Carcinoma |
Malignant Ovarian Brenner Tumor |
Ovarian Clear Cell Adenocarcinoma |
Ovarian Endometrioid Adenocarcinoma |
Ovarian Mucinous Adenocarcinoma |
Ovarian Seromucinous Carcinoma |
Ovarian Serous Adenocarcinoma |
Ovarian Transitional Cell Carcinoma |
Primary Peritoneal Serous Adenocarcinoma |
Stage IIA Fallopian Tube Cancer AJCC v6 and v7 |
Stage IIA Ovarian Cancer AJCC V6 and v7 |
Stage IIB Fallopian Tube Cancer AJCC v6 and v7 |
Stage IIB Ovarian Cancer AJCC v6 and v7 |
Stage IIC Fallopian Tube Cancer AJCC v6 and v7 |
Stage IIC Ovarian Cancer AJCC v6 and v7 |
Stage IIIA Fallopian Tube Cancer AJCC v7 |
Stage IIIA Ovarian Cancer AJCC v6 and v7 |
Stage IIIA Primary Peritoneal Cancer AJCC v7 |
Stage IIIB Fallopian Tube Cancer AJCC v7 |
Stage IIIB Ovarian Cancer AJCC v6 and v7 |
Stage IIIB Primary Peritoneal Cancer AJCC v7 |
Stage IIIC Fallopian Tube Cancer AJCC v7 |
Stage IIIC Ovarian Cancer AJCC v6 and v7 |
Stage IIIC Primary Peritoneal Cancer AJCC v7 |
Stage IV Fallopian Tube Cancer AJCC v6 and v7 |
Stage IV Ovarian Cancer AJCC v6 and v7 |
Stage IV Primary Peritoneal Cancer AJCC v7 |
Undifferentiated Fallopian Tube Carcinoma |
Undifferentiated Ovarian Carcinoma |
3 |
NCT00492778 |
Endometrial Adenocarcinoma |
Endometrial Adenosquamous Carcinoma |
Endometrial Clear Cell Adenocarcinoma |
Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation |
Endometrial Serous Adenocarcinoma |
Recurrent Uterine Corpus Carcinoma |
4 |
NCT00001337 |
Diffuse Large B-Cell Lymphoma (DLBCL) |
Primary Mediastinal Large B-cell Lymphoma |
Burkitt Lymphoma |
Anaplastic Large-Cell Lymphoma |
Gray Zone Lymphoma |
5 |
NCT00576654 |
Advanced Malignant Solid Neoplasm |
Estrogen Receptor Negative |
HER2/Neu Negative |
Hodgkin Lymphoma |
Metastatic Malignant Neoplasm |
Metastatic Malignant Solid Neoplasm |
Non-Hodgkin Lymphoma |
Progesterone Receptor Negative |
Stage III Breast Cancer AJCC v7 |
Stage III Colon Cancer AJCC v7 |
Stage III Lung Cancer AJCC v7 |
Stage III Ovarian Cancer AJCC v6 and v7 |
Stage III Pancreatic Cancer AJCC v6 and v7 |
Stage IIIA Breast Cancer AJCC v7 |
Stage IIIA Colon Cancer AJCC v7 |
Stage IIIA Ovarian Cancer AJCC v6 and v7 |
Stage IIIB Breast Cancer AJCC v7 |
Stage IIIB Colon Cancer AJCC v7 |
Stage IIIB Ovarian Cancer AJCC v6 and v7 |
Stage IIIC Breast Cancer AJCC v7 |
Stage IIIC Colon Cancer AJCC v7 |
Stage IIIC Ovarian Cancer AJCC v6 and v7 |
Stage IV Breast Cancer AJCC v6 and v7 |
Stage IV Colon Cancer AJCC v7 |
Stage IV Lung Cancer AJCC v7 |
Stage IV Ovarian Cancer AJCC v6 and v7 |
Stage IV Pancreatic Cancer AJCC v6 and v7 |
Stage IVA Colon Cancer AJCC v7 |
Stage IVB Colon Cancer AJCC v7 |
Triple-Negative Breast Carcinoma |
Unresectable Malignant Neoplasm |
Unresectable Solid Neoplasm |
6 |
NCT01012817 |
Metastatic Malignant Solid Neoplasm |
Recurrent Fallopian Tube Carcinoma |
Recurrent Ovarian Carcinoma |
Recurrent Primary Peritoneal Carcinoma |
Unresectable Solid Neoplasm |
7 |
NCT00956007 |
|
8 |
NCT00887146 |
|
9 |
NCT00983697 |
|
10 |
NCT00980954 |
|
11 |
NCT00981656 |
|
12 |
NCT00980460 |
PRETEXT Stage 1 Hepatoblastoma |
PRETEXT Stage 2 Hepatoblastoma |
PRETEXT Stage 3 Hepatoblastoma |
PRETEXT Stage 4 Hepatoblastoma |
13 |
NCT01013649 |
Pancreatic Acinar Cell Carcinoma |
Pancreatic Ductal Adenocarcinoma |
Pancreatic Intraductal Papillary-Mucinous Neoplasm |
Stage I Pancreatic Cancer AJCC v6 and v7 |
Stage IA Pancreatic Cancer AJCC v6 and v7 |
Stage IB Pancreatic Cancer AJCC v6 and v7 |
Stage II Pancreatic Cancer AJCC v6 and v7 |
Stage IIA Pancreatic Cancer AJCC v6 and v7 |
Stage IIB Pancreatic Cancer AJCC v6 and v7 |
14 |
NCT02085408 |
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome |
Adult Acute Megakaryoblastic Leukemia (M7) |
Adult Acute Minimally Differentiated Myeloid Leukemia (M0) |
Adult Acute Monoblastic Leukemia (M5a) |
Adult Acute Monocytic Leukemia (M5b) |
Adult Acute Myeloblastic Leukemia With Maturation (M2) |
Adult Acute Myeloblastic Leukemia Without Maturation (M1) |
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities |
Adult Acute Myeloid Leukemia With Del(5q) |
Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) |
Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) |
Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) |
Adult Acute Myelomonocytic Leukemia (M4) |
Adult Erythroleukemia (M6a) |
Adult Pure Erythroid Leukemia (M6b) |
Secondary Acute Myeloid Leukemia |
Untreated Adult Acute Myeloid Leukemia |
15 |
NCT01042522 |
Ovarian Granulosa Cell Tumor |
Ovarian Gynandroblastoma |
Ovarian Sertoli-Leydig Cell Tumor |
Ovarian Sex Cord Tumor With Annular Tubules |
Ovarian Sex Cord-Stromal Tumor |
Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types |
Ovarian Steroid Cell Tumor |
16 |
NCT01096368 |
Childhood Infratentorial Ependymoma |
Childhood Supratentorial Ependymoma |
Newly Diagnosed Childhood Ependymoma |
17 |
NCT01118026 |
|
18 |
NCT01101451 |
Cervical Adenocarcinoma |
Cervical Adenosquamous Carcinoma |
Cervical Squamous Cell Carcinoma, Not Otherwise Specified |
Stage IA Cervical Cancer |
Stage IB Cervical Cancer |
Stage IIA Cervical Cancer |
19 |
NCT01141231 |
Head and Neck Cancer |
Long-term Effects Secondary to Cancer Therapy in Adults |
Oral Complications of Chemotherapy and Head/Neck Radiation |
Radiation Toxicity |
Xerostomia |
20 |
NCT01366144 |
Breast Carcinoma |
Carcinoma of Unknown Primary Origin |
Endometrial Carcinoma |
Esophageal Carcinoma |
Lung Carcinoma |
Malignant Head and Neck Neoplasm |
Melanoma |
Ovarian Carcinoma |
Renal Pelvis and Ureter Urothelial Carcinoma |
Testicular Lymphoma |
21 |
NCT01051635 |
Neoplasms |
Lymphoma |
22 |
NCT01222754 |
Diffuse Intrinsic Pontine Glioma |
Anaplastic Astrocytoma |
High Grade Glioma |
23 |
NCT01386385 |
Large Cell Lung Carcinoma |
Lung Adenocarcinoma |
Lung Adenocarcinoma, Mixed Subtype |
Minimally Invasive Lung Adenocarcinoma |
Squamous Cell Lung Carcinoma |
Stage III Non-Small Cell Lung Cancer AJCC v7 |
Stage IIIA Non-Small Cell Lung Cancer AJCC v7 |
Stage IIIB Non-Small Cell Lung Cancer AJCC v7 |
24 |
NCT01381718 |
Brain and Central Nervous System Tumors |
Cognitive/Functional Effects |
Fatigue |
Neurotoxicity |
Psychosocial Effects of Cancer and Its Treatment |
25 |
NCT01190930 |
Acute Lymphoblastic Leukemia |
Adult B Lymphoblastic Lymphoma |
Ann Arbor Stage I B Lymphoblastic Lymphoma |
Ann Arbor Stage II B Lymphoblastic Lymphoma |
Childhood B Acute Lymphoblastic Leukemia |
Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 |
Childhood B Lymphoblastic Lymphoma |
Down Syndrome |
Hypodiploid B Acute Lymphoblastic Leukemia |
Intrachromosomal Amplification of Chromosome 21 |
Philadelphia Chromosome Positive |
Untreated Adult Acute Lymphoblastic Leukemia |
Untreated Childhood Acute Lymphoblastic Leukemia |
26 |
NCT01231906 |
Non-Metastatic Extraskeletal Ewing Sarcoma |
Peripheral Primitive Neuroectodermal Tumor of Bone |
Peripheral Primitive Neuroectodermal Tumor of Soft Tissues |
27 |
NCT01272037 |
Ductal Breast Carcinoma In Situ |
Estrogen Receptor and/or Progesterone Receptor Positive |
HER2/Neu Negative |
Invasive Breast Carcinoma |
Multicentric Breast Carcinoma |
Multifocal Breast Carcinoma |
Synchronous Bilateral Breast Carcinoma |
28 |
NCT01275664 |
Nausea and Vomiting |
Ovarian Brenner Tumor |
Ovarian Clear Cell Cystadenocarcinoma |
Ovarian Endometrioid Adenocarcinoma |
Ovarian Mucinous Cystadenocarcinoma |
Ovarian Seromucinous Carcinoma |
Ovarian Serous Cystadenocarcinoma |
Stage II Ovarian Cancer |
Stage IIA Fallopian Tube Cancer |
Stage IIA Ovarian Cancer |
Stage IIB Fallopian Tube Cancer |
Stage IIB Ovarian Cancer |
Stage IIC Fallopian Tube Cancer |
Stage IIC Ovarian Cancer |
Stage IIIA Fallopian Tube Cancer |
Stage IIIA Ovarian Cancer |
Stage IIIA Primary Peritoneal Cancer |
Stage IIIB Fallopian Tube Cancer |
Stage IIIB Ovarian Cancer |
Stage IIIB Primary Peritoneal Cancer |
Stage IIIC Fallopian Tube Cancer |
Stage IIIC Ovarian Cancer |
Stage IIIC Primary Peritoneal Cancer |
Stage IV Fallopian Tube Cancer |
Stage IV Ovarian Cancer |
Stage IV Primary Peritoneal Cancer |
Undifferentiated Ovarian Carcinoma |
29 |
NCT01359592 |
|
30 |
NCT01368588 |
|
31 |
NCT01434316 |
Advanced Malignant Solid Neoplasm |
BRCA1 Gene Mutation |
BRCA2 Gene Mutation |
32 |
NCT01406756 |
B Acute Lymphoblastic Leukemia |
Central Nervous System Leukemia |
Ph-Like Acute Lymphoblastic Leukemia |
Testicular Leukemia |
Untreated Adult Acute Lymphoblastic Leukemia |
Untreated Childhood Acute Lymphoblastic Leukemia |
33 |
NCT01497444 |
Kidney Cancer |
Liver Cancer |
34 |
NCT01503632 |
|
35 |
NCT01503086 |
Brain Neoplasm |
Recurrent Brain Neoplasm |
36 |
NCT01515787 |
|
37 |
NCT01333046 |
Hodgkin Lymphoma |
Non-Hodgkin Lymphoma |
Hodgkin Disease |
38 |
NCT01556243 |
|
39 |
NCT01573442 |
Arthralgia |
Breast Cancer |
Hot Flashes |
Musculoskeletal Complications |
Sexual Dysfunction |
40 |
NCT01587352 |
Ocular Melanoma With Extraocular Extension |
Recurrent Uveal Melanoma |
Stage IV Uveal Melanoma AJCC v7 |
41 |
NCT01585805 |
BRCA1 Gene Mutation |
BRCA2 Gene Mutation |
Metastatic Pancreatic Adenocarcinoma |
PALB2 Gene Mutation |
Pancreatic Adenocarcinoma |
Recurrent Pancreatic Carcinoma |
Stage III Pancreatic Cancer AJCC v6 and v7 |
Stage IV Pancreatic Cancer AJCC v6 and v7 |
42 |
NCT01638533 |
Glioma |
Lymphoma |
Metastatic Malignant Solid Neoplasm |
Neuroendocrine Neoplasm |
Recurrent Adult Soft Tissue Sarcoma |
Recurrent Bladder Carcinoma |
Recurrent Breast Carcinoma |
Recurrent Chronic Lymphocytic Leukemia |
Recurrent Colorectal Carcinoma |
Recurrent Head and Neck Carcinoma |
Recurrent Lung Carcinoma |
Recurrent Malignant Solid Neoplasm |
Recurrent Melanoma |
Recurrent Pancreatic Carcinoma |
Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma |
Recurrent Prostate Carcinoma |
Recurrent Renal Cell Carcinoma |
Recurrent Thyroid Gland Carcinoma |
Refractory Chronic Lymphocytic Leukemia |
Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma |
Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma |
Stage III Breast Cancer AJCC v7 |
Stage III Colorectal Cancer AJCC v7 |
Stage III Cutaneous Melanoma AJCC v7 |
Stage III Lung Cancer AJCC v7 |
Stage III Pancreatic Cancer AJCC v6 and v7 |
Stage III Prostate Cancer AJCC v7 |
Stage III Renal Cell Cancer AJCC v7 |
Stage III Soft Tissue Sarcoma AJCC v7 |
Stage IIIA Breast Cancer AJCC v7 |
Stage IIIA Colorectal Cancer AJCC v7 |
Stage IIIA Cutaneous Melanoma AJCC v7 |
Stage IIIB Breast Cancer AJCC v7 |
Stage IIIB Colorectal Cancer AJCC v7 |
Stage IIIB Cutaneous Melanoma AJCC v7 |
Stage IIIC Breast Cancer AJCC v7 |
Stage IIIC Colorectal Cancer AJCC v7 |
Stage IIIC Cutaneous Melanoma AJCC v7 |
Stage IV Breast Cancer AJCC v6 and v7 |
Stage IV Colorectal Cancer AJCC v7 |
Stage IV Cutaneous Melanoma AJCC v6 and v7 |
Stage IV Lung Cancer AJCC v7 |
Stage IV Pancreatic Cancer AJCC v6 and v7 |
Stage IV Prostate Cancer AJCC v7 |
Stage IV Renal Cell Cancer AJCC v7 |
Stage IV Soft Tissue Sarcoma AJCC v7 |
Stage IVA Colorectal Cancer AJCC v7 |
Stage IVB Colorectal Cancer AJCC v7 |
Unresectable Solid Neoplasm |
43 |
NCT01775475 |
AIDS-related Diffuse Large Cell Lymphoma |
AIDS-related Diffuse Mixed Cell Lymphoma |
AIDS-related Diffuse Small Cleaved Cell Lymphoma |
AIDS-related Immunoblastic Large Cell Lymphoma |
AIDS-related Lymphoblastic Lymphoma |
AIDS-related Peripheral/Systemic Lymphoma |
AIDS-related Small Noncleaved Cell Lymphoma |
Stage III AIDS-related Lymphoma |
Stage IV AIDS-related Lymphoma |
44 |
NCT01695941 |
Recurrent B-Cell Non-Hodgkin Lymphoma |
Recurrent Mantle Cell Lymphoma |
Refractory B-Cell Non-Hodgkin Lymphoma |
Refractory Mantle Cell Lymphoma |
45 |
NCT01595061 |
Stage IIIA Vulvar Cancer AJCC v7 |
Stage IIIB Vulvar Cancer AJCC v7 |
Stage IIIC Vulvar Cancer AJCC v7 |
Stage IVA Vulvar Cancer AJCC v7 |
Vulvar Squamous Cell Carcinoma |
46 |
NCT01602666 |
Central Nervous System Nongerminomatous Germ Cell Tumor |
Childhood Central Nervous System Germinoma |
47 |
NCT01622868 |
ERBB2 Gene Amplification |
HER2 Positive Breast Carcinoma |
Invasive Breast Carcinoma |
Metastatic Malignant Neoplasm in the Brain |
Recurrent Breast Carcinoma |
Stage IV Breast Cancer AJCC v6 and v7 |
48 |
NCT01649089 |
Cervical Adenocarcinoma |
Cervical Adenosquamous Carcinoma |
Cervical Squamous Cell Carcinoma, Not Otherwise Specified |
Lymphedema |
Sexual Dysfunction and Infertility |
Stage IA1 Cervical Cancer AJCC v6 and v7 |
Stage IA2 Cervical Cancer AJCC v6 and v7 |
Stage IB1 Cervical Cancer AJCC v6 and v7 |
49 |
NCT01674140 |
|
50 |
NCT01668719 |
DS Stage I Plasma Cell Myeloma |
DS Stage II Plasma Cell Myeloma |
DS Stage III Plasma Cell Myeloma |
51 |
NCT01711541 |
Head and Neck Squamous Cell Carcinoma |
Stage IVA Oropharyngeal Carcinoma AJCC v7 |
Stage IVB Oropharyngeal Carcinoma AJCC v7 |
52 |
NCT01711554 |
Recurrent Neuroblastoma |
Refractory Neuroblastoma |
53 |
NCT01781468 |
|
54 |
NCT01805076 |
Estrogen Receptor-negative Breast Cancer |
Progesterone Receptor-negative Breast Cancer |
Stage IA Breast Cancer |
Stage IB Breast Cancer |
Stage II Breast Cancer |
Triple-negative Breast Cancer |
55 |
NCT01730937 |
Adult Primary Hepatocellular Carcinoma |
Advanced Adult Primary Liver Cancer |
Recurrent Adult Primary Liver Cancer |
56 |
NCT01349881 |
|
57 |
NCT01789684 |
|
58 |
NCT01863550 |
|
59 |
NCT01749397 |
Stage IV Fallopian Tube Cancer AJCC v6 and v7 |
Stage IV Ovarian Cancer AJCC v6 and v7 |
Stage IV Primary Peritoneal Cancer AJCC v7 |
60 |
NCT01806129 |
|
61 |
NCT01586403 |
|
62 |
NCT01755195 |
|
63 |
NCT01767194 |
Ganglioneuroblastoma |
Recurrent Neuroblastoma |
64 |
NCT01089101 |
Low Grade Glioma |
Neurofibromatosis Type 1 |
Recurrent Childhood Pilocytic Astrocytoma |
Recurrent Childhood Visual Pathway Glioma |
65 |
NCT01872975 |
Stage IB Breast Cancer |
Stage II Breast Cancer |
66 |
NCT01771107 |
AIDS-Related Hodgkin Lymphoma |
Ann Arbor Stage II Hodgkin Lymphoma |
Ann Arbor Stage IIA Hodgkin Lymphoma |
Ann Arbor Stage IIB Hodgkin Lymphoma |
Ann Arbor Stage III Hodgkin Lymphoma |
Ann Arbor Stage IIIA Hodgkin Lymphoma |
Ann Arbor Stage IIIB Hodgkin Lymphoma |
Ann Arbor Stage IV Hodgkin Lymphoma |
Ann Arbor Stage IVA Hodgkin Lymphoma |
Ann Arbor Stage IVB Hodgkin Lymphoma |
Classic Hodgkin Lymphoma |
HIV Infection |
67 |
NCT01220583 |
|
68 |
NCT01824836 |
Estrogen Receptor-positive Breast Cancer |
Musculoskeletal Complications |
Progesterone Receptor-positive Breast Cancer |
Recurrent Breast Cancer |
Stage IA Breast Cancer |
Stage IB Breast Cancer |
Stage II Breast Cancer |
Stage IIIA Breast Cancer |
Stage IIIB Breast Cancer |
Stage IIIC Breast Cancer |
69 |
NCT01810913 |
Stage III Squamous Cell Carcinoma of the Hypopharynx |
Stage III Squamous Cell Carcinoma of the Larynx |
Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity |
Stage III Squamous Cell Carcinoma of the Oropharynx |
Stage III Verrucous Carcinoma of the Larynx |
Stage III Verrucous Carcinoma of the Oral Cavity |
Stage IV Squamous Cell Carcinoma of the Hypopharynx |
Stage IVA Squamous Cell Carcinoma of the Larynx |
Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity |
Stage IVA Squamous Cell Carcinoma of the Oropharynx |
Stage IVA Verrucous Carcinoma of the Larynx |
Stage IVA Verrucous Carcinoma of the Oral Cavity |
Stage IVB Squamous Cell Carcinoma of the Larynx |
Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity |
Stage IVB Squamous Cell Carcinoma of the Oropharynx |
Stage IVB Verrucous Carcinoma of the Larynx |
Stage IVB Verrucous Carcinoma of the Oral Cavity |
Tongue Cancer |
70 |
NCT01817075 |
Bacterial Infection |
Benign Neoplasm |
Malignant Neoplasm |
Methicillin-Resistant Staphylococcus Aureus Infection |
Myeloid Neoplasm |
Recurrent Childhood Acute Lymphoblastic Leukemia |
Recurrent Childhood Acute Myeloid Leukemia |
Untreated Childhood Myeloid Neoplasm |
71 |
NCT00978250 |
Head and Neck Neoplasms |
Lung Neoplasms |
Urinary Bladder Neoplasms |
Breast Neoplasms |
72 |
NCT01822496 |
Stage III Non-Small Cell Lung Cancer AJCC v7 |
Stage IIIA Non-Small Cell Lung Cancer AJCC v7 |
Stage IIIB Non-Small Cell Lung Cancer AJCC v7 |
73 |
NCT01822509 |
Hematopoietic Cell Transplantation Recipient |
Myelodysplastic Syndrome |
Myeloproliferative Neoplasm |
Previously Treated Myelodysplastic Syndrome |
Recurrent Adult Acute Lymphoblastic Leukemia |
Recurrent Adult Acute Myeloid Leukemia |
Recurrent Chronic Lymphocytic Leukemia |
Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive |
Recurrent Hodgkin Lymphoma |
Recurrent Non-Hodgkin Lymphoma |
Recurrent Plasma Cell Myeloma |
74 |
NCT01822522 |
Advanced Malignant Solid Neoplasm |
HIV Infection |
Metastatic Malignant Solid Neoplasm |
Recurrent Malignant Solid Neoplasm |
Unresectable Solid Neoplasm |
75 |
NCT01244737 |
|
76 |
NCT01841723 |
Hairy Cell Leukemia |
Hairy Cell Leukemia Variant |
77 |
NCT01849146 |
Adult Glioblastoma |
Recurrent Glioblastoma |
78 |
NCT01901094 |
Stage II Breast Cancer |
Stage IIIA Breast Cancer |
79 |
NCT01851369 |
Lymphomas |
Solid Tumors |
NSCLC |
Metastatic Colon Carcinoma |
Granulosa Cell Ovarian Cancer |
80 |
NCT01935934 |
Endometrial Adenosquamous Carcinoma |
Endometrial Clear Cell Adenocarcinoma |
Endometrial Mixed Adenocarcinoma |
Endometrial Serous Adenocarcinoma |
Metastatic Endometrioid Adenocarcinoma |
Recurrent Uterine Corpus Carcinoma |
Stage IV Uterine Corpus Cancer AJCC v7 |
Stage IVA Uterine Corpus Cancer AJCC v7 |
Stage IVB Uterine Corpus Cancer AJCC v7 |
Uterine Corpus Carcinosarcoma |
81 |
NCT01881867 |
Castration Levels of Testosterone |
Castration-Resistant Prostate Carcinoma |
Metastatic Prostate Carcinoma |
Stage IV Prostate Cancer |
82 |
NCT01534598 |
|
83 |
NCT01897012 |
High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements |
MYC Positive |
Recurrent B-Cell Non-Hodgkin Lymphoma |
Recurrent Burkitt Lymphoma |
Recurrent Diffuse Large B-Cell Lymphoma |
Recurrent Follicular Lymphoma |
Recurrent Hodgkin Lymphoma |
Recurrent Mantle Cell Lymphoma |
Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma |
Refractory B-Cell Non-Hodgkin Lymphoma |
Refractory Burkitt Lymphoma |
Refractory Diffuse Large B-Cell Lymphoma |
Refractory Follicular Lymphoma |
Refractory Hodgkin Lymphoma |
Refractory Mantle Cell Lymphoma |
Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma |
84 |
NCT01896999 |
Recurrent Classic Hodgkin Lymphoma |
Refractory Classic Hodgkin Lymphoma |
85 |
NCT01902173 |
Adult Solid Neoplasm |
Recurrent Colon Carcinoma |
Recurrent Melanoma |
Recurrent Ovarian Carcinoma |
Stage IIIC Colon Cancer |
Stage IIIC Ovarian Cancer |
Stage IIIC Skin Melanoma |
Stage IV Skin Melanoma |
86 |
NCT01953588 |
Estrogen Receptor-positive Breast Cancer |
HER2-negative Breast Cancer |
Invasive Ductal Breast Carcinoma |
Invasive Lobular Breast Carcinoma |
Recurrent Breast Cancer |
Stage II Breast Cancer |
Stage IIIA Breast Cancer |
Stage IIIB Breast Cancer |
Stage IIIC Breast Cancer |
87 |
NCT01912625 |
KRAS Activating Mutation |
Recurrent Non-Small Cell Lung Carcinoma |
Stage III Non-Small Cell Lung Cancer AJCC v7 |
Stage IIIA Non-Small Cell Lung Cancer AJCC v7 |
Stage IIIB Non-Small Cell Lung Cancer AJCC v7 |
88 |
NCT01925131 |
Acute Leukemias of Ambiguous Lineage |
B-cell Adult Acute Lymphoblastic Leukemia |
Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia |
Recurrent Adult Acute Lymphoblastic Leukemia |
Recurrent Adult Burkitt Lymphoma |
89 |
NCT00942877 |
|
90 |
NCT01273155 |
Neoplasms |
Lymphomas |
91 |
NCT01273168 |
Hormone Receptor-Positive Breast |
Gynecologic |
Desmoid |
Hormone Receptor-Positive Neoplasms |
92 |
NCT01362803 |
Neurofibromatosis 1 |
Neurofibromatosis Type 1 |
NF 1 |
Neurofibroma, Plexiform |
93 |
NCT01391962 |
|
94 |
NCT01572493 |
Lymphoma |
Carcinoma |
95 |
NCT01748825 |
Neoplasms |
Lymphoma |
96 |
NCT01827384 |
|
97 |
NCT01922076 |
Anaplastic Astrocytoma |
Anaplastic Oligoastrocytoma |
Diffuse Intrinsic Pontine Glioma |
Diffuse Midline Glioma, H3 K27M-Mutant |
Glioblastoma |
Gliosarcoma |
Untreated Childhood Anaplastic Astrocytoma |
Untreated Childhood Anaplastic Oligoastrocytoma |
Untreated Childhood Glioblastoma |
Untreated Childhood Gliosarcoma |
98 |
NCT01964300 |
|
99 |
NCT02004275 |
|
100 |
NCT01940809 |
BRAF V600E Mutation Present |
BRAF V600K Mutation Present |
Metastatic Melanoma |
Stage III Cutaneous Melanoma AJCC v7 |
Stage IIIA Cutaneous Melanoma AJCC v7 |
Stage IIIB Cutaneous Melanoma AJCC v7 |
Stage IIIC Cutaneous Melanoma AJCC v7 |
Stage IV Cutaneous Melanoma AJCC v6 and v7 |